DocGo (NASDAQ:DCGO – Get Free Report) had its target price decreased by equities research analysts at Canaccord Genuity Group from $10.00 to $9.00 in a research note issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 168.66% from […]